
At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.
Laurence Brunet, PhD, is the Senior Director of Epidemiology at Epividian, Inc. in Raleigh, NC, and a clinical epidemiologist specializing in the study of HIV comorbidities.

At CROI 2026, experts warned that missing HBV screening risks reactivation during HIV therapy switches.